These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7549225)

  • 1. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
    Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
    Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
    Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
    Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
    J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of dirithromycin: comparison with erythromycin.
    Bergogne-Bérézin E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dirithromycin concentrations in bronchial mucosa and secretions.
    Leroyer C; Muller-Serieys C; Quiot J; Benhamou D; Clavier J; Bergogne-Bérézin E
    Respiration; 1998; 65(5):381-5. PubMed ID: 9782221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.
    Dornbusch K; Olofsson C; Holm S
    APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM; Johns D; Sides GD
    J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
    Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
    Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna FD; Polverino M
    J Chemother; 1997 Aug; 9(4):279-84. PubMed ID: 9269609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-centre collaborative study for the in vitro evaluation of new macrolides dirithromycin and erythromycylamine. Australian Group for Antimicrobial Resistance (AGAR).
    Fernandes CJ; Benn RA; Nimmo GR
    Pathology; 1995 Jan; 27(1):74-8. PubMed ID: 7603759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.